Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Korosho to Take Measures to Improve Quality of Medical Services
October 28, 2002
- MEDICAL DEVICE NEWS IN BRIEF
October 28, 2002
- BUSINESS NEWS IN BRIEF -2-
October 21, 2002
- Hac-Kimisawa: Semi-annual Consolidated Sales Up 4.4%
October 21, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
October 21, 2002
- Kirindo: Sales, Profits Up in 1st Half
October 21, 2002
- Drugs Not Requiring Manufacturing or Import Approval Revised
October 21, 2002
- Terumo to Acquire Vascutek of Scotland
October 21, 2002
- PFSB to Put Top Priory on Post-marketing Safety
October 21, 2002
- Olympus to Provide Contents for WebSurg's Online Telesurgery Training Site
October 21, 2002
- REGULATORY NEWS IN BRIEF
October 21, 2002
- Toshiba Corp, Toshiba Medical: Architect c8000
October 21, 2002
- BULLETIN
October 21, 2002
- DIAGNOSTIC NEWS IN BRIEF
October 21, 2002
- The 61st Annual Meeting of the Japanese Cancer Associarion
October 21, 2002
- 21st IFPMA Assembly Held in Berlin
October 21, 2002
- Communication Is Most Important in Int'l Collaborative Studies: Prof. Uchida
October 21, 2002
- Korosho Study Group Recommends AUTs for OTC Drugs
October 21, 2002
- OTC NEWS IN BRIEF
October 21, 2002
- ON THE MOVE
October 21, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…